Precision BioSciences Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Precision BioSciences, Inc. (DTIL) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
Current Assets
Cash and Cash Equivalents85.90116.68189.58143.6689.80180.89
Short-Term Investments0.410.000.000.000.000.00
Cash & Short-Term Investments86.31116.68189.58143.6689.80180.89
Accounts Receivable1.700.900.720.4910.000.97
Inventory0.000.000.000.000.000.00
Other Current Assets6.440.421.230.170.002.32
Total Current Assets94.99136.36199.11161.75105.56193.67
Non-Current Assets
Property, Plant & Equipment (Net)10.1814.6013.7829.3341.5039.58
Long-Term Investments3.213.212.173.750.000.00
Intangible Assets0.620.400.732.051.370.00
Other Non-Current Assets22.790.2312.574.641.720.56
Total Non-Current Assets41.4023.4239.0649.7444.5941.57
Total Assets136.39159.78238.17211.50150.16235.24
Current Liabilities
Accounts Payable1.312.970.651.140.796.46
Short-Term Debt1.3222.410.000.000.000.00
Accrued Liabilities7.201.561.834.039.010.00
Deferred Revenue2.9612.0446.1921.2430.240.00
Other Current Liabilities2.194.904.210.989.871.58
Total Current Liabilities14.9849.9959.6635.9842.8324.53
Non-Current Liabilities
Long-Term Debt22.327.7222.222.488.590.00
Other Non-Current Liabilities2.990.130.200.040.392.40
Total Non-Current Liabilities65.0290.93118.0784.3562.9072.39
Total Liabilities80.00140.92177.74120.33105.7396.92
Stockholders' Equity
Common Stock0.000.000.000.000.000.00
Retained Earnings-482.46-489.63-428.31-316.68-286.07-177.07
Treasury Stock0.950.950.950.95-0.95-0.95
Additional Paid-in Capital539.81509.44489.70408.80331.45316.33
Shares Outstanding8.204.163.702.030.000.00
Total Stockholders' Equity56.3918.8660.4391.1744.43138.31
Total Liabilities & Equity136.39159.78238.17211.50150.16235.24